IE831259L - Polyfluorinated alcohol-containing composition. - Google Patents
Polyfluorinated alcohol-containing composition.Info
- Publication number
- IE831259L IE831259L IE831259A IE125983A IE831259L IE 831259 L IE831259 L IE 831259L IE 831259 A IE831259 A IE 831259A IE 125983 A IE125983 A IE 125983A IE 831259 L IE831259 L IE 831259L
- Authority
- IE
- Ireland
- Prior art keywords
- containing composition
- polyfluorinated alcohol
- component
- polyfluorinated
- alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/34—Halogenated alcohols
- C07C31/38—Halogenated alcohols containing only fluorine as halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical compositions having antineoplastic activity comprise as the active ingredient component a) which is at least one polyfluoroalcohol of formula I: CHF2-(CF2)n-CH2OH (I> wherein n is 3, 5, 7 or 9; and optionally component b) cholesterol. Preferably the compositions containing two and still better at least three polyfluoroalcohols. A lipophilic solvent may be present, for instance sesame oil.
[GB2121280A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8221553A IT8221553A0 (en) | 1982-05-28 | 1982-05-28 | PHARMACEUTICAL COMPOSITIONS ANTINEOPLASTIC ADAPTIVITY. |
Publications (2)
Publication Number | Publication Date |
---|---|
IE831259L true IE831259L (en) | 1983-11-28 |
IE55137B1 IE55137B1 (en) | 1990-06-06 |
Family
ID=11183507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1259/83A IE55137B1 (en) | 1982-05-28 | 1983-05-27 | Pharmaceutical compositions containing at least one polyfluorinated alcohol |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS591414A (en) |
AU (2) | AU552557B2 (en) |
BE (1) | BE896838A (en) |
CH (1) | CH653890A5 (en) |
DE (1) | DE3319304A1 (en) |
FR (1) | FR2527439A1 (en) |
GB (1) | GB2121280B (en) |
IE (1) | IE55137B1 (en) |
IL (1) | IL68796A0 (en) |
IN (1) | IN157042B (en) |
IT (1) | IT8221553A0 (en) |
LU (1) | LU84827A1 (en) |
NL (1) | NL8301899A (en) |
NZ (1) | NZ204393A (en) |
SE (1) | SE8302976L (en) |
ZA (1) | ZA833871B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3836971C1 (en) | 1988-10-31 | 1990-05-17 | Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3219004C1 (en) * | 1982-05-19 | 1984-03-01 | Philippine Dr. 8000 München Hartmann | Pharmaceutical compositions for the treatment of tumours |
-
1982
- 1982-05-28 IT IT8221553A patent/IT8221553A0/en unknown
-
1983
- 1983-05-20 CH CH2772/83A patent/CH653890A5/en not_active IP Right Cessation
- 1983-05-26 BE BE2/60100A patent/BE896838A/en not_active IP Right Cessation
- 1983-05-26 IL IL68796A patent/IL68796A0/en unknown
- 1983-05-26 SE SE8302976A patent/SE8302976L/en not_active Application Discontinuation
- 1983-05-26 GB GB08314540A patent/GB2121280B/en not_active Expired
- 1983-05-26 AU AU15000/83A patent/AU552557B2/en not_active Expired - Fee Related
- 1983-05-26 JP JP58093889A patent/JPS591414A/en active Pending
- 1983-05-27 IE IE1259/83A patent/IE55137B1/en unknown
- 1983-05-27 IN IN673/CAL/83A patent/IN157042B/en unknown
- 1983-05-27 ZA ZA833871A patent/ZA833871B/en unknown
- 1983-05-27 DE DE19833319304 patent/DE3319304A1/en not_active Ceased
- 1983-05-27 LU LU84827A patent/LU84827A1/en unknown
- 1983-05-27 FR FR8308776A patent/FR2527439A1/en not_active Withdrawn
- 1983-05-27 NL NL8301899A patent/NL8301899A/en not_active Application Discontinuation
- 1983-05-27 NZ NZ204393A patent/NZ204393A/en unknown
-
1988
- 1988-05-04 AU AU15570/88A patent/AU1557088A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SE8302976L (en) | 1983-11-29 |
IE55137B1 (en) | 1990-06-06 |
NZ204393A (en) | 1986-03-14 |
IT8221553A0 (en) | 1982-05-28 |
NL8301899A (en) | 1983-12-16 |
IL68796A0 (en) | 1983-09-30 |
GB2121280B (en) | 1985-08-29 |
CH653890A5 (en) | 1986-01-31 |
LU84827A1 (en) | 1983-11-17 |
AU1500083A (en) | 1983-12-01 |
AU552557B2 (en) | 1986-06-05 |
ZA833871B (en) | 1984-07-25 |
IN157042B (en) | 1986-01-04 |
GB8314540D0 (en) | 1983-06-29 |
AU1557088A (en) | 1988-11-10 |
FR2527439A1 (en) | 1983-12-02 |
DE3319304A1 (en) | 1983-12-01 |
BE896838A (en) | 1983-09-16 |
GB2121280A (en) | 1983-12-21 |
JPS591414A (en) | 1984-01-06 |
SE8302976D0 (en) | 1983-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE53301T1 (en) | SYSTEMS FOR IMPROVING PERFORMANCE AND THEIR PREPARATION. | |
IE812075L (en) | Composition | |
CA2031384A1 (en) | Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations | |
CA2009735A1 (en) | Insecticidally active nitro compounds | |
IE820137L (en) | Phosphoryl compounds | |
MY101847A (en) | Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof. | |
EP0957093A3 (en) | Retrovial protease inhibitors | |
IT8519189A0 (en) | PROCEDURE FOR THE PREPARATION OF VANADIUM COMPOUNDS FROM VANADIUM-CONTAINING RESIDUES. | |
AU6168190A (en) | Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient | |
EP0173664A3 (en) | Biologically active benzimidazole compounds and process for their preparation | |
WO1998010786A3 (en) | Pharmaceutical composition for the treatment of syndrome x of reaven | |
EP0031584A3 (en) | 2-substituted-aminopropene- and propanenitrile compounds and antimicrobial and pharmaceutical, anti-inflammatory compositions | |
AU8146587A (en) | New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | |
IE831259L (en) | Polyfluorinated alcohol-containing composition. | |
ZA935865B (en) | 17-(3-furyl) and 17-(4-pyridazinyl)-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same | |
CA2150244A1 (en) | Chlorofluoroether Compositions and Preparation Thereof | |
KR900003174A (en) | Benzofuro [3,2-C] quinoline compound | |
IE821319L (en) | Nematocidal compositions | |
AU590443B2 (en) | 2,3,4,5,6,7,-hexahydro-2,7-methano-1,5-benzoxazonine and -1,4-benzoxazonine compounds, processes for their preparation, and pharmaceutical compositions containing them | |
IE810760L (en) | Thiazoles | |
AR241084A1 (en) | COMPOUNDS DERIVED FROM PIRIDAZINE, FORMULATION AND FUNGICIDE COMPOSITION THAT UNDERSTAND THEM AND PROCEDURE TO PREPARE THEM ". | |
SE9004169D0 (en) | APPLICATION OF PHARMACEUTICAL AND COSMETIC COMPOSITIONS, CONTAINING 1,8-DIHYDROXY-10-PHENYL-9-ANTRON AS ACTIVE INGREDIENT | |
EP0239527A3 (en) | Composition adopted for use as a transdermal formulation | |
EP0056681A3 (en) | Levonantradol and n-methyllevonantradol formulations | |
IE791084L (en) | Antiviral compositions |